Company & Sponsor Intelligence
Neuronostics Ltd
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials4
Recruiting2
Completed1
Countries1
Therapeutic footprint
epilepsy
Indexed studies
NCT06546410OASIS: RetrOspective Analysis on EEGs for Identifying Seizure Susceptibility in paediatrIcs Using biomarkerS
epilepsy · United KingdomCOMPLETED
epilepsy · United KingdomCOMPLETED
NCT06669364A Retrospective Study to Validate BioEP as an Assessment Aid for Seizure Susceptibility
epilepsy · NOT_YET_RECRUITING
epilepsy · NOT_YET_RECRUITING
NCT06097195The Clinical Utility of BioEP in Diagnostic Decision Making in Epilepsy
epilepsy · United KingdomNA
epilepsy · United KingdomNA
NCT05764252A Prospective Diagnostic Belief Updating Study to verIfy the Utility of BioEP in First Seizure Clinics.
epilepsy · United KingdomUNKNOWN
epilepsy · United KingdomUNKNOWN
Intelligence layer updated: 2026-10-31 06:16:59.340585+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →